Medpace Holdings, Inc. - Common Stock (MEDP)

Historical Holders from Q3 2016 to Q3 2025

Symbol
MEDP on Nasdaq
CUSIP
58506Q109
Type / Class
Equity / Common Stock
Shares outstanding
28.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
24M
Holdings value
$12.3B
% of all portfolios
0.015%
Grand Portfolio weight change
-0.002%
Number of holders
659
Number of buys
314
Number of sells
-327
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Troendle August J. 20% +2.5% $3.39B -$200M 5.68M -5.57% August J. Troendle Nov 26, 2025

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 24M $12.3B -$1.14B $514.16 659
2025 Q2 26.4M $8.29B +$334M $313.86 593
2025 Q1 25.3M $7.72B -$9.72M $304.69 576
2024 Q4 25.3M $8.42B +$79.7M $332.23 579
2024 Q3 25.1M $8.38B -$157M $333.80 576
2024 Q2 25.1M $10.3B +$73.9M $411.85 618
2024 Q1 25M $10.1B +$239M $404.15 584
2023 Q4 24.6M $7.54B +$282M $306.53 532
2023 Q3 23.8M $5.76B -$41.4M $242.13 479
2023 Q2 23.8M $5.73B -$188M $240.17 455
2023 Q1 24.9M $4.67B +$108M $188.05 409
2022 Q4 24.3M $5.16B -$285M $212.41 413
2022 Q3 25.8M $4.05B -$88.3M $157.17 339
2022 Q2 26.3M $3.94B -$139M $149.67 325
2022 Q1 27.3M $4.47B -$289M $163.59 335
2021 Q4 28.6M $6.23B -$18M $217.64 376
2021 Q3 28.6M $5.42B +$198M $189.28 328
2021 Q2 27.6M $4.87B -$68.4M $176.63 319
2021 Q1 28M $4.59B +$104M $164.05 312
2020 Q4 27.7M $3.85B +$92.3M $139.20 305
2020 Q3 27.1M $3.03B -$135M $111.75 304
2020 Q2 28.4M $2.64B +$15M $93.02 268
2020 Q1 28.4M $2.09B -$34.3M $73.38 263
2019 Q4 28.8M $2.42B +$12.6M $84.06 247
2019 Q3 28.7M $2.41B -$89.3M $84.04 264
2019 Q2 30M $1.94B +$211M $65.42 218
2019 Q1 27.5M $1.62B -$96.5M $58.97 229
2018 Q4 29.2M $1.54B +$254M $52.93 214
2018 Q3 24.1M $1.45B +$618M $59.91 206
2018 Q2 13.9M $598M +$188M $43.00 144
2018 Q1 9.57M $334M +$31.5M $34.91 111
2017 Q4 8.57M $311M +$80.9M $36.26 113
2017 Q3 6.4M $204M +$6.84M $31.90 85
2017 Q2 6.31M $183M -$11M $29.00 78
2017 Q1 6.62M $198M -$7.56M $29.85 76
2016 Q4 7.26M $262M +$44.4M $36.07 79
2016 Q3 6.17M $184M +$184M $29.86 68